These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7924438)

  • 1. Cytotoxic T lymphocytes specific for influenza virus.
    McMichael A
    Curr Top Microbiol Immunol; 1994; 189():75-91. PubMed ID: 7924438
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some newly recognized aspects of resistance against and recovery from influenza.
    Ennis A
    Arch Virol; 1982; 73(3-4):207-17. PubMed ID: 6816194
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene cloning to study viral antigens: prospects for novel influenza and rotavirus vaccines.
    Both GW; Jennings PA
    Prog Vet Microbiol Immunol; 1987; 3():179-213. PubMed ID: 2856220
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.
    Budimir N; Meijerhof T; Wilschut J; Huckriede A; de Haan A
    Vaccine; 2010 Dec; 28(52):8280-7. PubMed ID: 20965298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.
    Lafont BAP; Bennink JR
    Viral Immunol; 2020 Apr; 33(3):197-200. PubMed ID: 32286176
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting of Influenza Viral Epitopes to Antigen-Presenting Cells by Genetically Engineered Chimeric Molecules in a Humanized NOD SCID Gamma Transfer Model.
    Ivanova II; Mihaylova NM; Manoylov IK; Makatsori D; Lolov S; Nikolova MH; Mamalaki A; Prechl J; Tchorbanov AI
    Hum Gene Ther; 2018 Sep; 29(9):1056-1070. PubMed ID: 30191743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.
    Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Curr Opin Biotechnol; 2007 Dec; 18(6):529-36. PubMed ID: 18083548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell recognition of influenza viral antigens.
    Lamb JR; McMichael AJ; Rothbard JB
    Hum Immunol; 1987 Jun; 19(2):79-89. PubMed ID: 2440836
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
    Anderson RW; Bennink JR; Yewdell JW; Maloy WL; Coligan JE
    Mol Immunol; 1992 Sep; 29(9):1089-96. PubMed ID: 1495499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the National Institutes of Health. Summary of a meeting on the origin of pandemic influenza viruses.
    Laver WG; Webster RG; Chu CM
    J Infect Dis; 1984 Jan; 149(1):108-15. PubMed ID: 6198405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to influenza in the elderly.
    Webster RG
    Vaccine; 2000 Feb; 18(16):1686-9. PubMed ID: 10689149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
    Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
    Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for the ideal influenza vaccine.
    Davenport FM
    Postgrad Med J; 1979 Feb; 55(640):78-86. PubMed ID: 461277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress and prospect of universal influenza vaccine].
    Luo DY; Xue CY; Cao YC
    Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.
    Sant AJ; Richards KA; Nayak J
    Curr Opin Immunol; 2018 Aug; 53():13-21. PubMed ID: 29621639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the antibody response in influenza virus infection.
    Gerhard W
    Curr Top Microbiol Immunol; 2001; 260():171-90. PubMed ID: 11443873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antigenic cartography of influenza viruses].
    Mary C
    Med Sci (Paris); 2009; 25(6-7):633-5. PubMed ID: 19602341
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognition of influenza virus proteins by cytotoxic T lymphocytes.
    Townsend A; Bastin J; Bodmer H; Brownlee G; Davey J; Gotch F; Gould K; Jones I; McMichael A; Rothbard J
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):527-33. PubMed ID: 2474170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.